Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
A literature review of the patent publications on venetoclax–a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent
N Žigart, Z Časar - Expert Opinion on Therapeutic Patents, 2019 - Taylor & Francis
Introduction: Studies presented in patents show that a novel chemotherapeutic agent,
venetoclax, might be useful in additional therapeutic indications. Venetoclax is approved in …
venetoclax, might be useful in additional therapeutic indications. Venetoclax is approved in …